Findings from a new study published in PLOS ONE, led by investigators at Dartmouth’s Geisel School of Medicine and Muhimibili University of Health and Allied Sciences, show high rates of new tuberculosis (TB) infection among adolescents in Tanzania—highlighting the importance of developing TB control measures for this high-risk age group.
Investigators at Dartmouth’s Geisel School of Medicine announced that two new studies of DAR-901, their investigational vaccine against tuberculosis (TB), have moved it to the forefront of new vaccines in development for global control of this deadly infectious disease.
Upcoming EventsThis page may link to PDF files. Use this link to download Adobe Reader if needed.